Effective treatment of allergic asthma and eczema

Airsonett^® Air4 is a medical device for effective home treatment of allergic asthma and eczema. The patented TLA technology provides 99.5% clean air in the breathing zone. Your airways and immune system can rest and recuperate when you sleep, and you wake up rested, ready for a new day.

Treatment with TLA is recommended by the Swedish National Board of Health and Welfare (Socialstyrelsen) and the Swedish paediatricians ‘allergy association (BLFA). It has also been reviewed in the UK by The National Institute for Health and Care Excellence (NICE) and proven cost effective by Health Improvement Scotland. Airsonett Air4 is a CE-marked medical device that meets the requirements according to MDR 2017/745, Class 1.

Physicians

Patients

Effective

Reducing exacerbations^1,2
Improved control of allergic diseases^1,3,4,5,6
Improved quality of life^3,4,5
No pharmacological side effects^1,2,3,4,5,6
Cost effective

1: Schauer et al, 2:Wang et al; 3: Boyle et al, 4: Pedroletti et al, 5: Gore C et al, 6: Traidl et al

Clinically proven

Treatment with Airsonett TLA is proven to reduce exacerbations and to reduce inflammation in the airways. The clinical effects are seen after 3 months (sleep improves in 1 month).

Clinical data

Economical

Health economics studies confirm lower treatment costs compared to pharmacological treatment options, fewer clinic visits and better control over patient symptoms.

This is how it works

Airsonett Air4 creates a zone of 99.5% clean air, free of particles and allergens around the face during night sleep. The airways and immune system rest and can withstand allergens even during the day.

Airsonett Air4